Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310

Y. Nieto, S. M. Tu, R. Bassett, R. B. Jones, A. M. Gulbis, N. Tannir, A. Kingham, C. Ledesma, K. Margolin, L. Holmberg, R. Champlin, L. Pagliaro

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310'. Together they form a unique fingerprint.